辅助-RSVPreF3疫苗在COPD患者中的吸收和有效性:全国性的丹麦队列研究
Maria João Fonseca1, Stanislava Bratković2, Yunus Çolak3
1GSK, Lisbon, Portugal.
Expert review of vaccines
|March 5, 2026
概括
辅助-RSVPreF3疫苗在预防60岁以上慢性阻塞性肺病 (COPD) 患者住院治疗呼吸道同胞性病毒 (RSV) 时显示100%的有效性. 将这种RSV疫苗整合到COPD护理中可以改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 患有慢性阻塞性肺病 (COPD) 的个人有较高的风险从呼吸道同胞性病毒 (RSV) 感染的严重结果.
- 辅助-RSVPreF3疫苗的目标是预防RSV在脆弱人群.
研究的目的:
- 评估60岁及以上COPD患者服用辅助RSVPreF3疫苗的情况.
- 评估辅助-RSVPreF3疫苗对RSV住院治疗在这个高危人群中的有效性.
主要方法:
- 为2024/25年RSV季节建立了丹麦全国60岁以上的COPD患者队列.
- 接种疫苗和未接种疫苗的个人使用倾向分数进行了匹配. 通过比较RSV住院率来计算疫苗的有效性.
- 随访发生在接种疫苗后21天,直到最早发生事件,数据结束,迁移或死亡.
主要成果:
- 在126,249名符合条件的个人中,5.9%接受了辅助RSVPreF3疫苗.
- 在接种疫苗的人群中,RSV住院率为每10万人/年0.0,而在未接种疫苗的人群中为200.6.
- 这导致疫苗对RSV住院治疗的估计有效率为100.0%,在接种疫苗的组中观察到其他RSV相关结果的发病率较低.
结论:
- 辅助RSVPreF3疫苗在预防COPD老年人RSV住院治疗方面表现出很高的有效性.
- 建议将RSV疫苗接种纳入常规COPD管理策略,以改善疾病的结果.
更多相关视频
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
982
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
982
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.3K
Common Respiratory Disorders
1.7K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.7K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Chronic Obstructive Pulmonary Disease
2.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.8K


